In a take one step backwards to help take 10 steps forward thinking i wonder if part of the reason of no eind’s/right to try in USA is strategic in the fact that US FDA will not have ANY lame excuses like although it wasn’t approved any doctor could request EIND use etc… with that now off the table only way to get in US is an EUA. The covid cases that were super high in Louisiana, Texas, FL will in the next several months will be transferring into the rest of the country as it gets colder and everyone is bottled up inside. Add in the fact that PO keep coming in from Phillipines and Brazil trial underway with other Brazil trial starting any day now put CYDY in best shape its ever been at $1.50 share highest Floor and Ceiling (Low risk - Very High Reward) add in couple bonus out lyres like cancer BTD request, Long haulers phase 2b/3 and nash results exciting times are back and approval i think has much higher chance this time around given the trial design of 4 doses, IV, and nee primary endpoint as well as the ridiculous unequal age difference from drug to placebo arm. Im not expecting this Brazil trial to be a homerun I’m expecting it to be a grand slam knocked out of the park….. like did anyone see how far into the parking lot the ball went. GLTA i think great days ahead await.